Literature DB >> 23480569

Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.

A Velazquez1, C A DeRyke, R Goering, V Hoover, M R Wallace.   

Abstract

Daptomycin non-susceptible Staphylococcus aureus was rarely encountered at our medical centre until 2010, when 10 isolates (0.4% of S. aureus) were confirmed by E-test as non-susceptible. These isolates were not of the same strain type and there was no link between the 10 patients. Daptomycin non-susceptibility may be increasing.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Antibiotic resistance; daptomycin; daptomycin resistance; staphylococcus aureus treatment; vancomycin

Mesh：

Substances：

Year:  2013        PMID： 23480569     DOI： 10.1111/1469-0691.12171

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  3 in total

1.  A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study).

Authors:  Thomas L Holland; William O'Riordan; Alison McManus; Elliot Shin; Ali Borghei; Thomas M File; Mark H Wilcox; Antoni Torres; Matthew Dryden; Thomas Lodise; Toyoko Oguri; G Ralph Corey; Patrick McLeroth; Rajesh Shukla; David B Huang
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

2.  Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.

Authors:  Kimberly C Claeys; Jordan R Smith; Anthony M Casapao; Ryan P Mynatt; Lisa Avery; Anjali Shroff; Deborah Yamamura; Susan L Davis; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

3.  The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections.

Authors:  Ewa Szczypinska; Alexander Velazquez; Diana Salazar; C Andrew Deryke; Beata Raczynski; Mark R Wallace
Journal:  Springerplus       Date:  2013-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.